Featured Drug Company Program

Eisai Reimbursement Resources


Eisai Reimbursement Resources is a program designed to offer drug-specific assistance related to the coding, coverage, and reimbursement of select drugs, as well as a variety of patient assistance services for patients who are prescribed Eisai’s drugs and who are having difficulty paying for the cost of their care.

For a list of oncology drugs covered through Eisai Reimbursement Resources and/or for patient assistance services, see the Table.

Table Eisai Oncology/Supportive Care Drugs
Drug Indications Patient support programs Contact information
Chemotherapy-induced nausea and vomiting Eisai Assistance Program www.eisaireimbursement.com/hcp/akynzeo/patient-support
Comarketed with Helsinn Healthcare Akynzeo Patient Assistance Program
Akynzeo Pay $0 Savings Program www.akynzeosavingsprogram.com
(palonosetron hydrochloride) injection
Chemotherapy-induced nausea
and vomiting
Eisai Assistance Program www.eisaireimbursement.com/hcp/aloxi/patient-support
Aloxi Patient Assistance Program
(eribulin mesylate)
Metastatic breast cancer; unresectable or metastatic liposarcoma Eisai Assistance Program www.eisaireimbursement.com/hcp/halaven/patient-support
Halaven $0 Co-Pay Program
Halaven Patient Assistance Program
Relapsed or refractory
ovarian cancer
Patient Assistance Program (in partnership with RxOutreach) www.eisaireimbursement.com/hcp/hexalen
Progressing differentiated thyroid cancer; advanced renal-cell cancer, in combination with everolimus Lenvima $0 Co-pay Program www.eisaireimbursement.com/patient/lenvima/financial-assistance
Eisai Patient Assistance Program
Eisai Assistance Program

The resources provided by Eisai Reimbursement Resources are drug-­specific; therefore, patients and providers are encouraged to visit www.eisaireimbursement.com and select their prescribed medication for more information on programs specific to that drug.

These resources are available for patients in a variety of care settings and with different types of insurance coverage, including government and commercial insurance.


Eisai Assistance Program

Through the drug-specific assistance programs, certain medications may be available at low cost or no cost to financially needy patients who meet the program’s eligibility criteria, including US residency, income status, and site-of-service specifications.

Coverage and payment depend on the patient’s insurance plan. Drug-­specific reimbursement information, insurance verification processing, prior authorization information, and guidance regarding denied claims may also be available with the Eisai Assistance Program.

For drug-specific information, please call the following phone numbers:

  • Akynzeo, Aloxi, Halaven, and Lenvima: 866-613-4724
  • Hexalen: 800-769-3880.

$0 Co-Pay Program

For commercially insured patients who have been prescribed an Eisai medication, drug-specific savings programs may be available. Using the $0 Co-Pay Program, most patients will pay $0 of their monthly out-of-pocket prescription cost, and Eisai will pay the balance of the noninsurance-covered portion, to a maximum of $1800 to $40,000 annually, depending on the drug.

Depending on the insurance plan, additional financial responsibilities may be required. The savings program cannot be used in combination with other coupons or offers, and is not available to patients with state or federal healthcare programs. For more information, visit the specific websites listed in the Table.

E.A.S.Y. Savings Program

The Eisai Assistance and Support for You (E.A.S.Y.) Savings Program provides patients taking Akynzeo, Halaven, or Lenvima a Pay $0 Savings Program. This savings program offers patients with commercial insurance $0 copay for each prescription, with an annual limit.

For patients who pay cash for Akynzeo, Eisai will pay up to $150 per prescription, for a maximum of $1800 per year. No activation or enrollment is required; restrictions apply.

Application & Enrollment

Completed Eisai Assistance Program enrollment forms should be faxed with a valid prescription to the number listed on the drug-specific form, which can be accessed via www.eisaireimbursement.com.

A copy of the patient’s insurance card, and any financial documents, should be attached. Accepted financial documents include a federal tax return, a Social Security benefit statement, 1 month of paycheck stubs, unemployment statements, or disability statements.

Receiving Eisai Medications

Depending on the type of medication and route of administration, Eisai’s medications may be available through specific specialty pharmacies (Accredo and Biologics) and mailed directly to the patient or to the healthcare facility or provider.